Biochemical markers of bone metabolism and bone mineral density in patients with type 2 diabetic foot ulcer.
Xu T., Sun Y., Huang P., Shi R., Yang J., Gu Y.
Prospective Study with a reported sample of 400 on Type 2 Diabetes, Diabetic Foot, published in BMC Endocr Disord (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- BMC Endocr Disord (2026)
- Country
- England
- Reported sample size
- 400
- Source database
- PubMed
- PMID
- 42210208
- DOI
- 10.1186/s12902-026-02328-5
Abstract (original English)
Type 2 diabetic foot ulcer (DFU) is closely linked to disorders of bone metabolism and abnormal bone mineral density (BMD), while serum 25-hydroxyvitamin D [25(OH)D], the gold standard for evaluating Vit D nutritional status, acts as an independent protective factor for DFU and is implicated in skeletal health regulation in diabetic patients. This cross-sectional study aimed to investigate biochemical markers of bone metabolism and BMD in patients with type 2 diabetic foot ulcer, and to identify risk factors for diabetic foot and accompanying gangrene. A total of 400 patients with type 2 diabetes mellitus (T2DM) admitted to the Endocrinology Ward of Affiliated Hospital of Nantong University from December 2021 to May 2023 were enrolled, including 155 in the DF group and 245 in the non-diabetic foot (NDF) group. Clinical data, bone metabolism markers and BMD measured by dual-energy X-ray absorptiometry (DXA) were collected, and data were analyzed using SPSS 25.0 software. Compared with the NDF group, the DF group had older age, longer diabetes duration, higher systolic blood pressure (SBP), urinary albumin creatinine ratio (UACR) and type I collagen N-terminal propeptide (PINP) level, but lower levels of serum albumin (ALB), glycemic and lipid indicators, 25(OH)D, total BMD and hip regional B < 0.05), with a significantly higher prevalence of low bone mass and osteoporosis. Binar
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level ASystematic ReviewEurope PMC
Dedifferentiation of Mature Adipocytes and Their Future Potential for Regenerative Medicine Applications
Systematic Review on Type 2 Diabetes, Chronic Wound, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level ASystematic ReviewEurope PMC
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis
Systematic Review on Type 2 Diabetes, Chronic Inflammation, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
- 2026
Food Sci Nutr - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level ASystematic ReviewPubMed
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysisEurope PMC
Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Meta-analysis on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol